Skip to content

Study · Not a test of the peptide alone · 1983

3 results

A comparison of high performance liquid chromatographic assays with the current pharmacopoeial assays for the combined formulation of ergometrine and oxytocin.

Pask-Hughes RA, Hartley RE, Gaines Das RE

Journal of biological standardization1 Jan 1983Cited by 5 (Europe PMC)

PMID6833302 (opens in a new tab)DOI10.1016/s0092-1157(83)80041-9 (opens in a new tab)PepBankPUB-06833302
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01LabNot a test of Oxytocin aloneOther designOther

    For the combined ergometrine and oxytocin formulation, chromatographic oxytocin estimates had significantly less variability than the Pharmacopoeial bioassay.

    In plain wordsIn lab testing, the chromatographic assay measured oxytocin with less variability than the bioassay.

    Peptide
    Oxytocin
    Outcome
    DecreaseOxytocin assay variability
    Study

    n: not reported in source

    Comparator
    Pharmacopoeial bioassay
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    The variability of estimates for ergometrine was similar for both procedures, whereas the variability of estimates of oxytocin content by chromatographic assay was significantly less than the variability of estimates by the Pharmacopoeial bioassay.
    1 context sentence
    Summary · context
    This paper reports the comparison of recently-developed chromatographic assays (using high performance liquid chromatography) with the present British Pharmacopoeial methods for the combined formulation of ergometrine and oxytocin.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  2. 02LabNot a test of Oxytocin aloneOther designOther

    For the combined ergometrine and oxytocin formulation, high-performance liquid-chromatography estimates agreed well with Pharmacopoeial determinations.

    In plain wordsIn lab testing, chromatographic estimates for the ergometrine-and-oxytocin formulation agreed well with Pharmacopoeial determinations.

    Peptide
    Oxytocin
    Outcome
    Not applicableAgreement of chromatographic oxytocin estimates
    Study

    n: not reported in source

    Comparator
    Pharmacopoeial determinations
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    This paper reports the comparison of recently-developed chromatographic assays (using high performance liquid chromatography) with the present British Pharmacopoeial methods for the combined formulation of ergometrine and oxytocin. The estimates using high performance liquid chromatography were in g…

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  3. 03LabNot a test of Oxytocin aloneOther designOther

    For the combined ergometrine and oxytocin formulation, high-performance liquid-chromatography oxytocin estimates agreed well with nominal contents.

    In plain wordsIn lab testing, chromatographic oxytocin estimates for the ergometrine-and-oxytocin formulation agreed well with stated contents.

    Peptide
    Oxytocin
    Outcome
    Not applicableAgreement of chromatographic oxytocin estimates with nominal contents
    Study

    n: not reported in source

    Comparator
    Nominal contents
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    This paper reports the comparison of recently-developed chromatographic assays (using high performance liquid chromatography) with the present British Pharmacopoeial methods for the combined formulation of ergometrine and oxytocin. The estimates using high performance liquid chromatography were in g…

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.